Skip to main content
. Author manuscript; available in PMC: 2017 Apr 7.
Published in final edited form as: J Mater Chem B. 2016 Mar 1;4(13):2264–2272. doi: 10.1039/C5TB02419F

Figure 7.

Figure 7

(A) ECC thrombus area and representative images of thrombogenicity chambers showing clot in the CarboSil® control ECC while the 10 µmole Argatroban/ CarboSil® coated chamber had virtually no clot. (B) Platelet count (×108/ml) over the ECC treatment time. Data values are means ± SEM and n=4. Significance was determined at p<0.05.